Donaldson Capital Management LLC Has $342,000 Position in Stryker Corporation (SYK)
Donaldson Capital Management LLC increased its holdings in Stryker Corporation (NYSE:SYK) by 12.6% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,461 shares of the medical technology company’s stock after purchasing an additional 275 shares during the quarter. Donaldson Capital Management LLC’s holdings in Stryker Corporation were worth $342,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also modified their holdings of the company. Bollard Group LLC raised its position in Stryker Corporation by 0.4% in the 2nd quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 3 shares during the period. James Investment Research Inc. purchased a new position in shares of Stryker Corporation in the second quarter valued at about $155,000. Guardian Life Insurance Co. of America increased its position in shares of Stryker Corporation by 0.8% in the first quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock valued at $158,000 after acquiring an additional 9 shares during the period. Assetmark Inc. increased its position in shares of Stryker Corporation by 0.3% in the first quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock valued at $168,000 after acquiring an additional 4 shares during the period. Finally, Mosaic Family Wealth LLC increased its position in shares of Stryker Corporation by 3.5% in the first quarter. Mosaic Family Wealth LLC now owns 1,300 shares of the medical technology company’s stock valued at $171,000 after acquiring an additional 44 shares during the period. Institutional investors own 74.18% of the company’s stock.
A number of equities analysts have issued reports on the stock. Zacks Investment Research cut shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, August 17th. BidaskClub cut shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Oppenheimer Holdings, Inc. set a $148.00 price objective on shares of Stryker Corporation and gave the company a “hold” rating in a research report on Friday, July 28th. Jefferies Group LLC restated a “hold” rating and issued a $132.00 price objective on shares of Stryker Corporation in a research report on Friday, June 30th. Finally, Cowen and Company restated a “buy” rating and issued a $160.00 price objective (up previously from $150.00) on shares of Stryker Corporation in a research report on Sunday, July 30th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the stock. Stryker Corporation presently has a consensus rating of “Hold” and an average price target of $145.73.
In other news, insider Graham A. Mclean sold 1,124 shares of the firm’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the transaction, the insider now directly owns 8,983 shares in the company, valued at approximately $1,313,853.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction on Friday, August 4th. The stock was sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the transaction, the insider now owns 88,207 shares in the company, valued at $12,909,976.52. The disclosure for this sale can be found here. Insiders sold a total of 25,429 shares of company stock worth $3,686,927 over the last quarter. Corporate insiders own 7.40% of the company’s stock.
Shares of Stryker Corporation (NYSE SYK) opened at 143.53 on Wednesday. The company has a market cap of $53.69 billion, a price-to-earnings ratio of 32.04 and a beta of 0.81. Stryker Corporation has a 1-year low of $106.48 and a 1-year high of $148.84. The company’s 50-day moving average is $143.99 and its 200 day moving average is $138.37.
Stryker Corporation (NYSE:SYK) last announced its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 EPS for the quarter, beating the Zacks’ consensus estimate of $1.51 by $0.02. The firm had revenue of $3.01 billion for the quarter, compared to analyst estimates of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The business’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same period last year, the company earned $1.39 EPS. Equities analysts anticipate that Stryker Corporation will post $6.46 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be given a $0.425 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.70 dividend on an annualized basis and a yield of 1.18%. Stryker Corporation’s payout ratio is 37.95%.
Stryker Corporation Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.